Form 8-K - Current report:
SEC Accession No. 0001437749-25-001566
Filing Date
2025-01-22
Accepted
2025-01-22 16:27:18
Documents
15
Period of Report
2025-01-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20250120_8k.htm   iXBRL 8-K 30457
2 EXHIBIT 10.4 ex_767713.htm EX-10.4 15349
  Complete submission text file 0001437749-25-001566.txt   184430

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20250115.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20250115_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20250115_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20250115_pre.xml EX-101.PRE 12019
17 EXTRACTED XBRL INSTANCE DOCUMENT nby20250120_8k_htm.xml XML 2950
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 25546276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)